SNG100, a novel topical treatment for moderate atopic dermatitis, in patients aged 6 years or older: A randomised, double‐blind, active‐controlled trial

BACKGROUND: Atopic dermatitis (AD) is one of the most common inflammatory skin diseases. It is associated with significant itch and impaired quality of life. Systemic treatments are efficient but associated with side effects. Novel topical treatments with a favourable safety profile are needed. SNG1...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuelov, Liat, Shemer, Avner, Greenberger, Shoshana, Ziv, Inbal, Friedman, Doron, Yacoby‐Zeevi, Oron, Dodiuk‐Gad, Roni, Ramot, Yuval, Murad, Sari, Sprecher, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690700/
https://www.ncbi.nlm.nih.gov/pubmed/38047249
http://dx.doi.org/10.1002/ski2.293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690700/
https://www.ncbi.nlm.nih.gov/pubmed/38047249
http://dx.doi.org/10.1002/ski2.293

Ejemplares similares